Sartorius Aktiengesellschaft (XETRA:SRT.DE)
| Market Cap | 13.84B+13.1% |
| Revenue (ttm) | 3.58B+3.3% |
| Net Income | 196.10M+28.2% |
| EPS | 2.83+87.4% |
| Shares Out | 34.24M |
| PE Ratio | 70.85 |
| Forward PE | 30.78 |
| Dividend | €0.73(0.35%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 2,778 |
| Open | 206.00 |
| Previous Close | 206.50 |
| Day's Range | 199.80 - 206.00 |
| 52-Week Range | 158.20 - 215.50 |
| Beta | 1.45 |
| Analysts | Buy |
| Price Target | 251.08(+25.23%) |
| Earnings Date | Oct 22, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About SRT.DE
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$SRT.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SRT.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SRT.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SRT.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SRT.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SRT.DE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in SRT.DE
| ETF | Est. Holding Size |
|---|---|
| ZDEUSPDR Solactive Germany ETF | $285.98K |
| NTSIWisdomTree International Efficient Core Fund | $214.86K |
| TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF | $159.25K |
| WIMAWisdomTree International Adaptive Moving Average Fund | $40.05K |
| AFTYPacer CSOP FTSE China A50 ETF | $1.93K |
| VDGVanguard Developed Markets ex US Growth Index ETF | $1.37K |
Estimated from each fund’s disclosed top holdings × AUM
SRT.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SRT.DE’s recent data — informational, not investment advice